53
Research Trials
20
Peer-reviewed publications
16
Clinical Conditions
Hyfe pilot study tests a digital therapeutic combining passive cough monitoring with behavioral suppression techniques delivered through the CoughPro app.
This narrative review by Hyfe's R&D team makes the case that continuous cough monitoring (CCM), powered by acoustic AI, transforms cough from a subjective symptom into a quantifiable digital biomarker.
Independent ERS 2025 NeuroCOUGH trial uses the Hyfe Cough Tracker to test feasibility of studying azithromycin's effect on cough and oesophageal motility.
Independent ERS 2025 trial uses the Hyfe Cough Tracker to show azithromycin reduces objective cough frequency by week one in chronic respiratory disease.
13.10.2023
Authors: Seung-Eun Lee, Matthew Rudd, Tae-Hwa Kim, Ji-Yoon Oh, Ji-Hyang Lee, Lola Jover, Peter M Small, Kian Fan Chung, Woo-Jung Song
This study focused on evaluating the Hyfe Cough Tracker. This mobile app, equipped with cough-counting AI algorithms, was used to monitor cough frequency in patients with chronic cough over a minimum period of one week. The research involved 65 subjects, with 43 completing the study.
Key findings included a median monitoring duration of 13.9 days with high adherence, variations in cough frequency, and a correlation between objective and subjective cough measures.
The study concluded that continuous monitoring is essential due to the significant day-to-day variability in cough frequency, emphasizing its importance in clinical practice and trials. The majority of participants found the monitoring helpful and easy to use, indicating the potential utility of such technology in managing chronic cough conditions
